Xavier Brown, MD

A postdoctoral associate at Yale School of Medicine whose research focuses on transthyretin amyloid cardiomyopathy (ATTR-CM), with an emphasis on early detection, diagnostic pathways, and clinical outcomes. Dr. Brown's research interests include the evaluation and implementation of artificial intelligence–enabled approaches to support early disease recognition and clinical decision-making. He is particularly interested in translating these approaches into clinical workflows to facilitate timely diagnosis and improve access to cardiovascular care to underserved communities.